Zacks Research issued their FY2027 earnings estimates for shares of Charles River Laboratories International in a report ...
Stock analysts at Zacks Research boosted their FY2027 earnings estimates for shares of Bank of New York Mellon in a report issued on Tuesday, March 11th. Zacks Research analyst R. Department now ...
A recent ransomeware attack targeted Zacks, an American investment firm, and a cybercriminal claimed to have stolen records ...
2d
Zacks Investment Research on MSNAnalysts Estimate FactSet Research (FDS) to Report a Decline in Earnings: What to Look Out forWall Street expects a year-over-year decline in earnings on higher revenues when FactSet Research (FDS) reports results for the quarter ended February 2025. While this widely-known consensus outlook ...
The fund pursues its investment objectives by applying a hybrid research process, which uses both quantitative and qualitative criteria. The Advisor uses the Zacks Rank, a proprietary model ...
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Zacks Investment Research recently disclosed that it suffered a data breach that compromised the sensitive personal data of millions of individuals ...
Chicago, IL – February 19, 2025 – Today, Zacks Equity Research discusses BYD Co Ltd BYDDY, Geely Auto GELYY and XPeng Inc. XPEV. Companies in the Zacks Automotive – Foreign industry are ...
Below are three quality stocks to buy off the rising 200-day moving average: Zacks Rank #2 (Buy) stock On Holding is an emerging leader in the running shoe category. The company has delivered ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results